Delivery Order SPE2DB22D3501-SPE2DB25FUY80

Award Date 3/19/25
Potential Completion Date 4/9/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed-price delivery order is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 25, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed-price delivery order contract provides LORBRENA 100 MG TABLET 30S, a specialty pharmaceutical product, with a period of performance through February 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,344.30, is for the delivery of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LORBRENA 100MG TAB 30S, a pharmaceutical product, with a ceiling value of $22,688.62 and a period of performance through March 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $22,688.62 contract is for the supply of LORBRENA 100 MG TABLET 30S, a prescription medication, with a performance period through May 2025. The award is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LORBRENA 100 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $21,156.78 and a completion date of April 1, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of LORBRENA 100 MG TABLET 30S, a prescription medication. The firm-fixed-price delivery order has a total ceiling value of $11,344.30 and runs through January 23, 2025. The contract is not designated as a set-aside and is a standalone award, not associated with a larger contract vehicle. Amerisourcebergen, a for-profit organization,...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award, valued at $21,156.78, is a firm fixed-price delivery order contract for the supply of the medication Lorbrena 100 mg Tablet with a completion date of December 26, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,271.84 firm-fixed-price delivery order contract is for the supply of the drug Lynparza 100 mg tablets. The award has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $42,270.40 delivery order is for the supply of Lynparza 150 mg tablets and is under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with the DLA that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUY80
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,688.62 firm fixed price delivery order is for the drug LORBRENA 100 MG TABLET 30S, with a performance period ending on April 9, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

The contract award was not designated with any set-aside requirements, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 6/18/25, 11:06 AM